DLEU2 and prostate carcinoma: RT-qPCR and western blotting indicated that SGK1 was distinctly upregulated in DLEU2-overexpressing prostate cancer cells (Fig. 3D) and downregulated in DLEU2-knockdown cells (Fig. 3E, F).